Recurrent LRP1-SNRNP25 and KCNMB4-CCND3 fusion genes promote tumor cell motility in human osteosarcoma

Journal of Hematology and Oncology

Volumn 7, Issue 1, 2014, Pages

  Yang, Jilong ^a   Annala, Matti ^b   Ji, Ping ^c   Wang, Guowen ^a   Zheng, Hong ^a   Codgell, David ^c   Du, Xiaoling ^a   Fang, Zhiwei ^d   Sun, Baocun ^a   Nykter, Matti ^b   Chen, Kexin ^a   Zhang, Wei ^c  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c UNIVERSITY OF TEXAS   (United States)

^d PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

Fusion gene; KCNMB4 CCND3; LRP1 SNRNP25; Osteosarcoma; Transcriptome sequencing

Indexed keywords

PROTEIN P53; TRANSCRIPTOME; CCND3 PROTEIN, HUMAN; CYCLIN D3; KCNMB4 PROTEIN, HUMAN; LARGE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL BETA SUBUNIT; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; LRP1 PROTEIN, HUMAN; NERVE PROTEIN; SMALL NUCLEAR RIBONUCLEOPROTEIN; SNRNP25 PROTEIN, HUMAN;

ADOLESCENT; ADULT; ARTICLE; CANCER PROGNOSIS; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CHROMOSOME REARRANGEMENT; CLINICAL ARTICLE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FUSION GENE; GENE ACTIVATION; GENE EXPRESSION; GENE IDENTIFICATION; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC REGULATION; HUMAN; HUMAN TISSUE; KCNMB4 CCND3 FUSION GENE; LRP1 SNRNP25 FUSION GENE; MALE; OSTEOSARCOMA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; SAOS 2 CELL LINE; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR GENE; TUMOR INVASION; TUMOR RECURRENCE; BONE TUMOR; CELL MOTION; COHORT ANALYSIS; GENE FUSION; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; BONE NEOPLASMS; CELL MOVEMENT; COHORT STUDIES; CYCLIN D3; FEMALE; GENE FUSION; HUMANS; LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNEL BETA SUBUNITS; LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-1; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; OSTEOSARCOMA; RIBONUCLEOPROTEINS, SMALL NUCLEAR; TRANSCRIPTOME; YOUNG ADULT;

EID: 84907933570     PISSN: None     EISSN: 17568722     Source Type: Journal    
DOI: 10.1186/s13045-014-0076-2     Document Type: Article

References (32)

1. CDM Fletcher, JA Bridge, PCW Hogendoorn, F Mertens, World Health Organization Classification of Tumours of Soft Tissue and Bone IARC Press, Lyon 2013
2. Advances in sarcoma genomics and new therapeutic targets. BS Taylor, J Barretina, RG Maki, CR Antonescu, S Singer, M Ladanyi, Nat Rev Cancer 2011 11 541 557 10.1038/nrc3087 21753790
3. Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy. J Barretina, BS Taylor, S Banerji, AH Ramos, M Lagos-Quintana, PL Decarolis, K Shah, ND Socci, BA Weir, A Ho, DY Chiang, B Reva, CH Mermel, G Getz, Y Antipin, R Beroukhim, JE Major, C Hatton, R Nicoletti, M Hanna, T Sharpe, TJ Fennell, K Cibulskis, RC Onofrio, T Saito, N Shukla, C Lau, S Nelander, SJ Silver, C Sougnez, et al. Nat Genet 2010 42 715 721 10.1038/ng.619 20601955
4. The impact of translocations and gene fusions on cancer causation. F Mitelman, B Johansson, F Mertens, Nat Rev Cancer 2007 7 233 245 10.1038/nrc2091 17361217
5. Molecular genetics of sarcomas: applications to diagnoses and therapy. J Toguchida, T Nakayama, Cancer Sci 2009 100 1573 1580 10.1111/j.1349-7006.2009.01232.x 19555393
6. A new subtype of bone sarcoma defined by BCOR-CCNB3 gene fusion. G Pierron, F Tirode, C Lucchesi, S Reynaud, S Ballet, S Cohen-Gogo, V Perrin, JM Coindre, O Delattre, Nat Genet 2012 44 461 466 10.1038/ng.1107 22387997
7. Systematic identification of genomic markers of drug sensitivity in cancer cells. MJ Garnett, EJ Edelman, SJ Heidorn, CD Greenman, A Dastur, KW Lau, P Greninger, IR Thompson, X Luo, J Soares, Q Liu, F Iorio, D Surdez, L Chen, RJ Milano, GR Bignell, AT Tam, H Davies, JA Stevenson, S Barthorpe, SR Lutz, F Kogera, K Lawrence, A McLaren-Douglas, X Mitropoulos, T Mironenko, H Thi, L Richardson, W Zhou, F Jewitt, et al. Nature 2012 483 570 575 10.1038/nature11005 22460902
8. Reprogramming of mesenchymal stem cells by the synovial sarcoma-associated oncogene SYT-SSX2. CB Garcia, CM Shaffer, MP Alfaro, AL Smith, J Sun, Z Zhao, PP Young, MN VanSaun, JE Eid, Oncogene 2012 31 2323 2334 10.1038/onc.2011.418 21996728
9. PAX3/FOXO1 fusion gene status is the key prognostic molecular marker in rhabdomyosarcoma and significantly improves current risk stratification. E Missiaglia, D Williamson, J Chisholm, P Wirapati, G Pierron, F Petel, JP Concordet, K Thway, O Oberlin, K Pritchard-Jones, O Delattre, M Delorenzi, J Shipley, J Clin Oncol 2012 30 1670 1677 10.1200/JCO.2011.38.5591 22454413
10. Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor. JE Butrynski, DR D'Adamo, JL Hornick, JE Butrynski, DR D'Adamo, JL Hornick, P Dal Cin, CR Antonescu, SC Jhanwar, M Ladanyi, M Capelletti, SJ Rodig, N Ramaiya, EL Kwak, JW Clark, KD Wilner, JG Christensen, PA Jänne, RG Maki, GD Demetri, GI Shapiro, N Engl J Med 2010 363 1727 1733 10.1056/NEJMoa1007056 20979472
11. p53 and MDM2 alterations in osteosarcomas: correlation with clinicopathologic features and proliferative rate. F Lonardo, T Ueda, AG Huvos, J Healey, M Ladanyi, Cancer 1997 79 1541 1547 10.1002/(SICI)1097-0142(19970415)79:8<1541::AID-CNCR15>3.0.CO;2-Y 9118036
12. Comprehensive mapping of p53 pathway alterations reveals an apparent role for both SNP309 and MDM2 amplification in sarcomagenesis. M Ito, L Barys, T O'Reilly, M Ito, L Barys, T O'Reilly, S Young, B Gorbatcheva, J Monahan, S Zumstein-Mecker, PF Choong, I Dickinson, P Crowe, C Hemmings, J Desai, DM Thomas, J Lisztwan, Clin Cancer Res 2011 17 416 426 10.1158/1078-0432.CCR-10-2050 21159888
13. Characterization of the 12q15 MDM2 and 12q13-14 CDK4 amplicons and clinical correlations in osteosarcoma. S Mejia-Guerrero, M Quejada, N Gokgoz, M Gill, RK Parkes, JS Wunder, IL Andrulis, Genes Chromosomes Cancer 2010 49 518 525 20196171
14. Molecular alterations of the RB1, TP53, and MDM2 genes in primary and xenografted human osteosarcomas. A Pellin, J Boix-Ferrero, D Carpio, A Pellín, J Boix-Ferrero, D Carpio, D López-Terrada, C Carda, S Navarro, A Peydró-Olaya, TJ Triche, A Llombart-Bosch, Diagn Mol Pathol 1997 6 333 341 10.1097/00019606-199712000-00005 9559293
15. IDH1 and IDH2 mutations, immunohistochemistry and associations in a series of brain tumors. M Mellai, A Piazzi, V Caldera, O Monzeglio, P Cassoni, G Valente, D Schiffer, J Neurooncol 2011 105 345 357 10.1007/s11060-011-0596-3 21643842
16. IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours. MF Amary, K Bacsi, F Maggiani, S Damato, D Halai, F Berisha, R Pollock, P O'Donnell, A Grigoriadis, T Diss, M Eskandarpour, N Presneau, PC Hogendoorn, A Futreal, R Tirabosco, AM Flanagan, J Pathol 2011 224 334 343 10.1002/path.2913 21598255
17. Conventional chondrosarcoma in a survivor of rhabdoid tumor: enlarging the spectrum of tumors associated with SMARCB1 germline mutations. F Forest, A David, S Arrufat, G Pierron, D Ranchere-Vince, JL Stephan, A Clemenson, O Delattre, F Bourdeaut, Am J Surg Pathol 2012 36 1892 1896 10.1097/PAS.0b013e31826cbe7a 23154773
18. Imatinib mesylate as a preoperative therapy in dermatofibrosarcoma: results of a multicenter phase II study on 25 patients. D Kérob, R Porcher, O Vérola, S Dalle, E Maubec, F Aubin, M D'Incan, I Bodokh, S Boulinguez, I Madelaine-Chambrin, A Mathieu-Boue, JM Servant, E de Kerviler, A Janin, F Calvo, F Pedeutour, C Lebbe, Clin Cancer Res 2010 16 3288 3295 10.1158/1078-0432.CCR-09-3401 20439456
19. Histone deacetylase 5 represses the transcription of cyclin D3. S Roy, AC Shor, TK Bagui, E Seto, WJ Pledger, J Cell Biochem 2008 104 2143 2154 10.1002/jcb.21771 18404677
20. MiR-138 induces cell cycle arrest by targeting cyclin D3 in hepatocellular carcinoma. W Wang, LJ Zhao, YX Tan, H Ren, ZT Qi, Carcinogenesis 2012 33 1113 1120 10.1093/carcin/bgs113 22362728
21. MicroRNA-195 plays a tumor-suppressor role in human glioblastoma cells by targeting signaling pathways involved in cellular proliferation and invasion. QQ Zhang, H Xu, MB Huang, LM Ma, QJ Huang, Q Yao, H Zhou, LH Qu, J Neurooncol 2012 14 278 287
22. The structure of CDK4/cyclin D3 has implications for models of CDK activation. T Takaki, A Echalier, NR Brown, T Hunt, JA Endicott, ME Noble, Proc Natl Acad Sci U S A 2009 106 4171 4176 10.1073/pnas.0809674106 19237555
23. A novel EWSR1-CREB3L1 fusion transcript in a case of small cell osteosarcoma. LVML Debelenko, BR Shivakumar, HD Dorfman, SC Raimondi, Genes Chromosomes Cancer 2011 50 1054 1062 10.1002/gcc.20923 21987447
24. Effects of low density lipoprotein receptor-related protein-1 on the expression of platelet-derived growth factor beta-receptor in vitro. L Wu, S Arandjelovic, SL Gonias, J Cell Biochem 2004 93 1169 1177 10.1002/jcb.20288 15486970
25. Secreted heat shock protein 90alpha induces colorectal cancer cell invasion through CD91/LRP-1 and NF-kappaB-mediated integrin alphaV expression. JS Chen, YM Hsu, CC Chen, LL Chen, CC Lee, TS Huang, J Biol Chem 2010 285 25458 25466 10.1074/jbc.M110.139345 20558745
26. The integrated landscape of driver genomic alterations in glioblastoma. V Frattini, V Trifonov, JM Chan, A Castano, M Lia, F Abate, ST Keir, AX Ji, P Zoppoli, F Niola, C Danussi, I Dolgalev, P Porrati, S Pellegatta, A Heguy, G Gupta, DJ Pisapia, P Canoll, JN Bruce, RE McLendon, H Yan, K Aldape, G Finocchiaro, T Mikkelsen, GG Privé DD Bigner, A Lasorella, R Rabadan, A Iavarone, Nat Genet 2013 45 1141 1149 10.1038/ng.2734 23917401
27. Fusion genes in solid tumors: an emerging target for cancer diagnosis and treatment. BC Parker, W Zhang, Chin J Cancer 2013 32 594 603 10.5732/cjc.013.10178 24206917
28. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. D Kim, G Pertea, C Trapnell, H Pimentel, R Kelley, SL Salzberg, Genome Biol 2013 14 36 10.1186/gb-2013-14-4-r36 23618408
29. The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastoma. BC Parker, MJ Annala, DE Cogdell, KJ Granberg, Y Sun, P Ji, X Li, J Gumin, H Zheng, L Hu, O Yli-Harja, H Haapasalo, T Visakorpi, X Liu, CG Liu, R Sawaya, GN Fuller, K Chen, FF Lang, M Nykter, W Zhang, J Clin Invest 2013 123 855 865 23298836
30. ChimeraScan: a tool for identifying chimeric transcription in sequencing data. MK Iyer, AM Chinnaiyan, CA Maher, Bioinformatics 2011 27 2903 2904 10.1093/bioinformatics/btr467 21840877
31. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. B Langmead, C Trapnell, M Pop, SL Salzberg, Genome Biol 2009 10 25 10.1186/gb-2009-10-3-r25 19261174
32. Genetic amplification of the vascular endothelial growth factor (VEGF) pathway genes, including VEGFA, in human osteosarcoma. J Yang, D Yang, Y Sun, B Sun, G Wang, JC Trent, DM Araujo, K Chen, W Zhang, Cancer 2011 117 4925 4938 10.1002/cncr.26116 21495021